ESSA Pharma Inc at Jefferies London Healthcare Conference Transcript

Nov 17, 2022 / 03:15PM GMT
Kevin Strang - Jefferies Financial Group Inc. - Analyst

Hi. My name is Kevin Strang. I'm one of the biotech associates here at Jefferies. It's my pleasure today to introduce ESSA Pharma for a fireside chat. I have here with me, David Parkinson, CEO; Peter Virsik, the COO; and David Wood, the CFO. And it's going to be a fireside-chat format. And with that, thank you for joining us today, management.

David Parkinson - ESSA Pharma Inc. - President, CEO & Director

Appreciate the opportunity. Thank you, Kevin.

Kevin Strang - Jefferies Financial Group Inc. - Analyst

And so yeah, we can just dive in if you wouldn't mind telling me, for those who don't know as well, a little bit about ESSA Pharma, and maybe give us a one-minute intro highlighting your main products.

David Parkinson - ESSA Pharma Inc. - President, CEO & Director

Certainly, well ESSA is a small biopharma company focused on small-molecule development to inhibit androgen male hormone biology. That's particularly

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot